HOME >> MEDICINE >> NEWS
Key event in cell death occurs as single, quick event

Scientists at St. Jude Children's Research Hospital have demonstrated that a key event during apoptosis (cell suicide) occurs as a single, quick event, rather than as a step-by-step process. Apoptosis eliminates extraneous cells from the developing body; and disposes of cells that sustain irreparable harm to their DNA or are infected with microorganisms. The researchers photographed individual cells undergoing that process, allowing investigators to observe the release of certain proteins from pores in the membranes of mitochondria. These cellular structures contain enzymes that extract energy from food molecules, and the space within the membrane surrounding them holds a variety of proteins that are released during apoptosis.

Results of the study indicate the formation of pores in the mitochondrial membranes is a rapid process that allows a nearly simultaneous rather than a sequential release of many apoptosis proteins, according to Douglas Green, Ph.D., chair of the St. Jude Department of Immunology. Green is senior author of a report on this work that appears in the August 1 issue of Proceedings of the National Academy of Sciences. The process of pore formation, called mitochondrial outer membrane permeabilization (MOMP), allows apoptosis proteins stored underneath the membrane to escape and orchestrate the cell's destruction.

MOMP is controlled by a family of proteins called Bcl-2; some of these support apoptosis and others interrupt the process. The pro- and anti-apoptotic Bcl-2 proteins cooperate to weigh and balance cell signals that promote survival or death, in this way determining the final outcome. During apoptosis, these proteins are either already on the mitochondrial membranes or migrate to the membranes, where they trigger MOMP.

"The slow, continuous release of one of the proteins, apoptosis-inducing factor (AIF), suggests that the pore formed during MOMP remains open for many hours," Green said. "Our finding of nearly simulta
'"/>

Contact: Bonnie Kourvelas
bonnie.kourvelas@stjude.org
901-495-4815
St. Jude Children's Research Hospital
1-Aug-2006


Page: 1 2

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Using MRI for diagnosis could help prevent breast cancer progression
3. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
4. Bioengineering to prevent iron deficiency?
5. Preventive treatments in elderly people needs rethinking
6. Should adult male circumcision be recommended for HIV prevention in the US?
7. Scaling up HIV prevention programs is cost effective
8. Early-morning Friday classes may prevent students from getting sloppy on thirsty Thursdays
9. Catastrophic events can affect a persons sleep
10. Meningitis: effectiveness of preventive vaccination demonstrated
11. Study tests oral insulin to prevent type 1 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Key event cell death occurs single quick event

(Date:5/23/2013)... The sodium theory has ... B. Katz in the early 1950s, after their experiments ... sodium and potassium ions in nerve functions . ... techniques have known amazing developments. In The Sodium Theory ... an account of the latest developments in the field ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Voyance, ... and perception management tools, and ASCA, the industry’s ... the new ASCA Benchmarking Program. Voyance ... technology and national benchmarking experience to support ASCA’s ... comprehensive, state-of-the-art benchmarking tool. , “Voyance is both ...
(Date:5/23/2013)... Park, FL (PRWEB) May 23, 2013 ... Day Belly Blast Diet to determine what makes this ... , The published review highlights three main components of ... rate; achieving a positive mindset and the personal motivation ... calorie intake every 7 days to keep the metabolism ...
(Date:5/23/2013)... eat at fast-food restaurants are consuming significantly more calories ... offenders, a new study found. "Teens underestimate the ... as 34 percent, parents of school-age children by as ... as 20 percent," study lead researcher, Dr. Jason Block, ... Johnson Foundation, which helped fund the study. ...
(Date:5/23/2013)... Susquehanna Health is now ... babysitting training course for adolescents age 11 and up. ... pediatrician Dr. Patricia Keener after a colleague’s toddler choked ... sitter who didn’t know how to provide first aid. ... a medical basis that aims to reduce the number ...
Breaking Medicine News(10 mins):Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. ... biopharmaceutical company focused on the development and commercialization of ... such as primary biliary cirrhosis, today announced that ... Executive Officer, will present at the Deutsche Bank Securities ... on Wednesday, May 29, 2013 at 4:10 ...
(Date:5/23/2013)...  Omeros Corporation (NASDAQ: OMER ) ... (IND) to evaluate OMS824 in Huntington,s disease has ... Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), ... linked to a wide range of diseases that ... has shown promising results in animal models directly ...
(Date:5/23/2013)... 23, 2013  MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
Cached News: